Notably, it has been demonstrated that MARCH1 is highly expressed in human hepatocellular carcinoma (HCC) cells (55), MARCH5 is up-regulated in ovarian cancer tissues (28), and MARCH8 is highly expressed in esophageal tumors and associated with tumor aggression (50). Here, MARCHF8 is linked to hepatocellular carcinoma.